✦ LIBER ✦

Trends in Utilization and Outcomes of Autologous Transplantation as Early Therapy for Multiple Myeloma

✍ Scribed by Costa, Luciano J.; Zhang, Mei-Jie; Zhong, Xiaobo; Dispenzieri, Angela; Lonial, Sagar; Krishnan, Amrita; Freytes, Cesar; Vesole, David; Gale, Robert Peter; Anderson, Kenneth; Wirk, Baldeep; Savani, Bipin N.; Waller, Edmund K.; Schouten, Harry; Lazarus, Hillard; Meehan, Kenneth; Sharma, Manish; Kamble, Rammurti; Vij, Ravi; Kumar, Shaji; Nishihori, Taiga; Kindwall-Keller, Tamila; Saber, Wael; Hari, Parameswaran N.

Book ID: 123424216
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 885 KB
Volume: 19
Category: Article
ISSN: 1083-8791
DOI: 10.1016/j.bbmt.2013.08.002

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Race and Outcomes of Autologous Hematopo

Race and Outcomes of Autologous Hematopoietic Cell Transplantation for Multiple Myeloma

✍ Parameswaran N. Hari; Navneet S. Majhail; Mei-Jie Zhang; Anna Hassebroek; Fareeh 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 181 KB

Early versus delayed autologous stem cel

Early versus delayed autologous stem cell transplant in patients receiving novel therapies for multiple myeloma

✍ Dunavin, Neil C.; Wei, Lai; Elder, Patrick; Phillips, Gary S.; Benson, Don M.; H 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 326 KB

Results of autologous and allogeneic hem

Results of autologous and allogeneic hematopoietic cell transplant therapy for multiple myeloma

✍ Arora, M; McGlave, P B; Burns, L J; Miller, J S; Barke, J N; Defor, T E; Weisdor 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 155 KB

Current Trends in Autologous Stem-Cell T

Current Trends in Autologous Stem-Cell Transplantation for Myeloma in the Era of Novel Therapies

✍ Moreau, P.; Avet-Loiseau, H.; Harousseau, J.-L.; Attal, M. 📂 Article 📅 2011 🏛 American Society of Clinical Oncology 🌐 English ⚖ 105 KB

BU and CY as conditioning regimen for au

BU and CY as conditioning regimen for autologous transplant in patients with multiple myeloma

✍ Talamo, G; Claxton, D F; Dougherty, D W; Ehmann, C W; Sivik, J; Drabick, J J; Ry 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 204 KB

Busulfan, cyclophosphamide, and etoposid

Busulfan, cyclophosphamide, and etoposide as conditioning for autologous stem cell transplantation in multiple myeloma

✍ Christopher R. Cogle; Jan S. Moreb; Helen L. Leather; Katarzyna J. Finiewicz; Sh 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB 👁 2 views

## Abstract Autologous stem cell transplantation (ASCT) has enabled the use of high‐dose alkylating agents either as a single agent or in combination with other cytotoxic agents and/or total body irradiation (TBI) for the treatment of multiple myeloma. Despite improved complete remission rates, rel